Related Experiment Video
Updated: Apr 6, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive
Yang Zhou1, Ruochuan Zang1, Zhao Li2
1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Abstract:
Lung adenocarcinoma (LUAD) presents a paradoxical association between SHOX2 DNA hypermethylation-a well-validated diagnostic biomarker-and its transcriptional overexpression, challenging conventional methylation-cancer biology paradigms. Through validation in our clinical cohort (n = 142) and functional experiments, we demonstrate that SHOX2 overexpression is linked to oncogenic activation, correlates with advanced TNM stage (P = 0.0161), poor tumor differentiation (P = 0.0418), and reduced overall survival (HR = 1.583, 95% CI:1.027-2.442), establishing its role as an independent prognostic factor (multivariate Cox HR = 1.704, P = 0.021). Mechanistically, systematic literature/patent analyses revealed that commercially utilized SHOX2 hypermethylation biomarkers (e.g. Epi proLung BL, LungMe® kits) target CpG sites within the first intron-a gene body region whose methylation enhances oncogenic transcription-rather than promoter regions. Integrative TCGA-LUAD methylation profiling and demethylation experiments (5-aza-dC treatment in H1650/SK-LU-1/H1975/A549/H1299/H322/HCC827/H358 cells) further establish a dual regulatory mechanism: promoter hypomethylation (cg25694447/cg26129769 sites, P < 0.0001) and gene body hypermethylation (cg09220088/cg04521004 sites, P < 0.0001) cooperatively drive SHOX2 overexpression. This spatial resolution explains the high specificity of SHOX2 methylation-based diagnostics despite tumor overexpression, resolving longstanding contradictions. Our findings redefine epigenetic regulation in LUAD, demonstrating that regional methylation patterns-not global promoter status-orchestrate oncogene activation. We propose a novel framework for spatially resolved methylomics, advocating 1) dual-target assays monitoring both promoter and gene body methylation to improve diagnostic precision, and 2) therapeutic exploitation of SHOX2's intronic methylome as a druggable epigenetic switch.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

